You are viewing the site in preview mode

Skip to main content

Table 4 Univariate and multivariate Cox regression analyses of overall survival risk factors in 77 HCC patients post - hepatectomy

From: An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy

Characteristic

all

HR (univariable)

HR (multivariable)

Treg

Low

51 (66.2%)

  
 

High

26 (33.8%)

2.78 (1.27–6.11, p = 0.011)

4.59 (1.82–11.59, p = 0.001)

Sex

female

14 (18.2%)

  
 

male

63 (81.8%)

2.86 (0.67–12.13, p = 0.154)

 

Age

Mean ± SD

57.9 ± 11.8

0.98 (0.95–1.02, p = 0.310)

 

HBV.DNA

< 1000 IU/mL

49 (63.6%)

  
 

> 1000 IU/mL

28 (36.4%)

3.28 (1.47–7.32, p = 0.004)

3.89 (1.36–11.11, p = 0.011)

AFP

< 400 ng/mL

47 (61.0%)

  
 

> 400 ng/mL

30 (39.0%)

1.54 (0.70–3.38, p = 0.279)

 

TBIL

Median [Min, Max]

14.8 [6.50, 141]

1.01 (1.00-1.03, p = 0.096)

 

ALB

Mean ± SD

39.0 ± 4.5

0.87 (0.79–0.96, p = 0.006)

0.89 (0.79-1.00, p = 0.058)

PT

Median [Min, Max]

11.9 [1.1, 24.9]

1.03 (0.90–1.18, p = 0.694)

 

Operation. time

Median [Min, Max]

212 [89.0, 582]

1.00 (1.00-1.01, p = 0.549)

 

Blood. loss

≤ 300mL

60 (77.9%)

  
 

¬ 300mL

17 (22.1%)

1.37 (0.57–3.28, p = 0.484)

 

Hepatectomy

≤ 2 segmentectomy

63 (81.8%)

  
 

> 2 segmentectomy

14 (18.2%)

0.47 (0.14–1.59, p = 0.224)

 

Tumor. diameter

< 5 cm

37 (48.1%)

  
 

> 5 cm

40 (51.9%)

2.99 (1.24–7.16, p = 0.014)

0.98 (0.31–3.15, p = 0.973)

Satellite. nodules

No

59 (76.6%)

  
 

Yes

18 (23.4%)

2.78 (1.24–6.26, p = 0.013)

2.45 (0.84–7.14, p = 0.099)

MVI

No

40 (51.9%)

  
 

Yes

37 (48.1%)

3.00 (1.28–7.01, p = 0.011)

1.86 (0.69–4.99, p = 0.219)

Differentiation

Medium-high

42 (54.5%)

  
 

Low

35 (45.5%)

2.02 (0.91–4.49, p = 0.086)

 
  1. n = 77, events = 25, Likelihood ratio test = 31.67 on 6 df(p < 0.001)
  2. Abbreviations: HCC, Hepatocellular carcinoma; HR, hazard ratio; OS, overall survival; Treg, regulatory T cells; AFP, alpha-fetoprotein; PT, prothrombin time; ALB, albumin; TBIL, total bilirubin; MVI, microvascular invasion;